1. Brunel University Research Archive
  2. University
  3. Publications
Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/20161
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLee, H-
dc.contributor.authorKim, J-
dc.contributor.authorKang, YA-
dc.contributor.authorKim, DR-
dc.contributor.authorSim, B-
dc.contributor.authorZelmer, A-
dc.contributor.authorFletcher, HA-
dc.contributor.authorDockrell, HM-
dc.contributor.authorSmith, SG-
dc.contributor.authorCho, S-N-
dc.date.accessioned2020-02-03T15:11:22Z-
dc.date.available2020-02-03T15:11:22Z-
dc.date.issued2019-04-26-
dc.identifier.citationFrontiers in Immunology, 10en_US
dc.identifier.issnhttp://dx.doi.org/10.3389/fimmu.2019.00896-
dc.identifier.issn1664-3224-
dc.identifier.issnhttp://dx.doi.org/10.3389/fimmu.2019.00896-
dc.identifier.issn1664-3224-
dc.identifier.issnhttp://dx.doi.org/10.3389/fimmu.2019.00896-
dc.identifier.issn1664-3224-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/20161-
dc.description.abstractIt is important to understand the ability to inhibit mycobacterial growth in healthy adults who would have been Bacillus Calmette-Guérin (BCG) vaccinated in childhood as this group will be the potential target population for novel booster TB vaccine trials. In this study we investigated not only the long-term immunity induced by childhood BCG vaccination but also protective immunity in terms of the ability to inhibit mycobacterial growth in those who were BCG vaccinated in childhood, with evidence of recent or remote TB infection.en_US
dc.description.sponsorshipThis study was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) founded by the Ministry of Science, ICT and Future Planning (NRF-2015K1A3A7A03073714) and from the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) founded by the Ministry for Health, Welfare, and Family Affairs, Republic of Korea (HI14C1324). LSHTM and ITRC are partners in a grant under the MRC-KHIDI UK-Korea Partnering Award scheme awarded to HL and SS with Grant No. HI17C0324 and MC_PC_17109 in TBVAC2020 supported by the European Commission under the H2020 program, with Grant No. 643381; the ITRC group was funded by a Grant (NRF-2015K1A3A7A03073714).en_US
dc.language.isoenen_US
dc.publisherFrontiers Media SAen_US
dc.subjectmycobacterial growth inhibitionen_US
dc.subjectcorrelatesen_US
dc.subjectvaccineen_US
dc.subjecttuberculosisen_US
dc.subjectlatent tuberculosis infectionen_US
dc.titleIn vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infectionen_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.3389/fimmu.2019.00896-
dc.relation.isPartOfFrontiers in Immunology-
pubs.publication-statusPublished online-
pubs.volume10-
dc.identifier.eissn1664-3224-
Appears in Collections:Publications

Files in This Item:
File Description SizeFormat 
Fulltext.pdf1.57 MBAdobe PDFView/Open
Show simple item record


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.